HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reduction of fluconazole susceptibility of Candida albicans in APECED patients due to long-term use of ketoconazole and miconazole.

Abstract
We have analysed further the y of usage of antifungals in autoimmune polyendocrinopathy - candidiasis - ectodermal dystrophy (APECED) patients and its impact on the susceptibility to fluconazole in Candida albicans. Data were obtained from patient records up to 30 y earlier. Analysing the use of azoles preceding isolation of each isolate showed that significantly more y of azole usage preceded isolation of C. albicans with decreased susceptibility to fluconazole than isolation of susceptible isolates. This was found to be mainly due to the usage of azoles other than fluconazole. Significantly more y of usage of ketoconazole and miconazole preceded the isolation of strains with decreased susceptibility to fluconazole than susceptible isolates (p=0.0241 and 0.0012, respectively). These results highlight that also topical compounds, in particular miconazole, may influence fluconazole susceptibility. Our data indicate that discretion should be used in the long-term use of all azoles, including topical miconazole. At the same time topical amphotericin B appears to be a safe choice as resistance is very rare despite y of usage.
AuthorsRiina Rautemaa, Malcolm Richardson, Michael Pfaller, Jaakko Perheentupa, Harri Saxen
JournalScandinavian journal of infectious diseases (Scand J Infect Dis) Vol. 40 Issue 11-12 Pg. 904-7 ( 2008) ISSN: 0036-5548 [Print] England
PMID18651265 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antifungal Agents
  • Miconazole
  • Fluconazole
  • Ketoconazole
Topics
  • Antifungal Agents (administration & dosage, therapeutic use)
  • Candida albicans (drug effects)
  • Drug Administration Schedule
  • Drug Resistance, Fungal
  • Fluconazole (pharmacology)
  • Humans
  • Ketoconazole (administration & dosage, therapeutic use)
  • Miconazole (administration & dosage, therapeutic use)
  • Polyendocrinopathies, Autoimmune (microbiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: